AIMD logo

Ainos, Inc. Stock Price

NasdaqCM:AIMD Community·US$14.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AIMD Share Price Performance

US$1.91
-0.61 (-24.15%)
US$1.91
-0.61 (-24.15%)
Price US$1.91

AIMD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with worrying balance sheet.

7 Risks
0 Rewards

Ainos, Inc. Key Details

US$18.1k

Revenue

US$3.8k

Cost of Revenue

US$14.3k

Gross Profit

US$14.0m

Other Expenses

-US$13.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.89
79.15%
-76,996.25%
242.7%
View Full Analysis

About AIMD

Founded
1984
Employees
41
CEO
Chun-Hsien Tsai
WebsiteView website
www.ainos.com

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Recent AIMD News & Updates

Recent updates

No updates